Background pattern
Medicine image

Spedra 100 mg comprimidos

About the medication

Introduction

Patient Information Leaflet

Spedra 100 mg Tablets

avanafil

Read this leaflet carefully before you start taking this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.
  • If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  1. Possible side effects
  2. Storage of Spedra
  1. Contents of the pack and additional information

1. What is Spedra and how is it used

Spedra contains the active ingredient avanafilo. It belongs to a group of medicines called type 5 phosphodiesterase inhibitors (PDE5). Spedra is a treatment for adult males who suffer from erectile dysfunction (also known as impotence). This occurs when a male is unable to achieve or maintain a firm erection to engage in sexual intercourse.

Spedra works by helping the blood vessels in your penis to relax. This increases blood flow to the penis, helping it to remain hard and erect after sexual stimulation. Spedra does not cure your condition.

It is essential that you know that Spedra only works if you receive sexual stimulation. You and your partner must perform prior sexual stimulation to prepare for sex, just as you would without taking a medication to help you.

Spedra will not help you if you do not suffer from erectile dysfunction. Spedra is not indicated for women.

2. What you need to know before starting Spedra

Do not take Spedra:

  • if you are allergic to avanafilo or any of the other components of this medication (listed in section 6).
  • if you are taking medications with “nitrates” for chest pain (angina), such as amyl nitrite or glyceryl trinitrate. Spedra may potentiate the effects of these medications and significantly decrease your blood pressure.
  • if you are taking medications for HIV or AIDS, such as ritonavir, indinavir, saquinavir, nelfinavir, or atazanavir
  • if you are taking medications for fungal infections, such as ketoconazole, itraconazole, or voriconazole, or certain antibiotics for bacterial infections, such as clarithromycin or telithromycin
  • if you have a severe heart problem
  • if you have had a stroke or heart attack in the last 6 months
  • if you have uncontrolled hypertension or hypotension
  • if you have chest pain (angina) or if you experience chest pain during sexual intercourse if you have a severe liver or heart problem
  • if you have lost vision in one eye due to insufficient blood flow to the eye (non-arteritic anterior ischemic optic neuropathy [NAION])
  • if you have a family history of certain eye problems (such as retinitis pigmentosa).
  • If you are taking riociguat. This medication is used to treat pulmonary arterial hypertension (elevated blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (elevated blood pressure secondary to blood clots). PDE5 inhibitors have shown an increase in the hypotensive effects of this medication. Consult your doctor if you are taking riociguat or are unsure.

Do not take Spedra if you are in any of the above situations. If you are unsure, consult your doctor or pharmacist before taking Spedra.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Spedra:

  • if you have heart problems. Having sex may pose a risk to you
  • if you have priapism, that is, a persistent erection that lasts 4 hours or more. This can occur in men with conditions such as sickle cell anemia, multiple myeloma, or leukemia
  • if you have a physical problem that affects the shape of your penis (such as curvature, Peyronie's disease, or cavernosal fibrosis)
  • if you have a bleeding disorder or active peptic ulceration.

If you are in any of the above situations, consult your doctor or pharmacist before starting to take Spedra. In case of doubt, consult your doctor or pharmacist.

Visual or auditory problems

Some men who take medications like Spedra have experienced visual and auditory problems, see “Serious adverse reactions”, in section 4 for detailed information. It is not known if these problems are directly related to Spedra, other conditions you may have, or a combination of factors.

If you experience sudden vision loss or loss of vision, or if your vision is distorted or blurred while taking Spedra, stop taking Spedra and contact your doctor immediately.

Children and adolescents

Spedra is not indicated for use in children or adolescents under 18 years old.

Use of Spedra with other medications

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, as Spedra may affect the activity of some medications. Additionally, other medications may affect the activity of Spedra.

Specifically, inform your doctor and do not take Spedra if you are taking medications with “nitrates” for chest pain (angina), such as amyl nitrite or glyceryl trinitrate. It has been shown that Spedra potentiates the effects of these medications and significantly decreases your blood pressure. Do not take Spedra if you are taking medications for HIV or AIDS, such as ritonavir, indinavir, saquinavir, nelfinavir, or atazanavir, or if you are taking medications for fungal infections, such as ketoconazole, itraconazole, or voriconazole, or certain antibiotics for bacterial infections, such as clarithromycin or telithromycin (see the beginning of section 2, “Do not take Spedra”).

Inform your doctor or pharmacist if you are taking any of the following medications:

  • medications called “alpha-blockers”, for prostate problems or to lower blood pressure
  • medications for irregular heartbeat (“arrhythmia”), such as quinidine, procainamide, amiodarone, or sotalol
  • antibiotics for infections, such as erythromycin
  • phenobarbital or primidone, for epilepsy
  • carbamazepine, for epilepsy, for mood stabilization, or for certain types of pain
  • other medications that may reduce the breakdown of Spedra in the body (“moderate inhibitors of CYP3A4”), such as amprenavir, aprepitant, diltiazem, fluconazole, fosamprenavir, and verapamil.
  • riociguat

Do not use Spedra with other treatments for erectile dysfunction, such as sildenafil, tadalafil, or vardenafil.

If you are in any of the above situations, consult your doctor or pharmacist before taking Spedra. In case of doubt, consult your doctor or pharmacist.

Use of Spedra with beverages and alcohol

Orange juice may increase exposure to the medication and should be avoided within 24 hours of taking Spedra.

Consuming alcohol at the same time as Spedra may accelerate heart rate and lower blood pressure. You may feel dizzy (especially when standing), experience headaches, or feel heart palpitations. Alcohol consumption may reduce your ability to achieve an erection.

Fertility

No effects on sperm movement or structure were observed after a single oral dose of 200 mg of avanafilo in healthy volunteers.

Repeated oral administration of avanafilo 100 mg for a period of 26 weeks in healthy volunteers and in men with mild erectile dysfunction did not associate with any adverse effects on sperm concentration, count, motility, or morphology.

Driving and operating machinery

Spedra may cause dizziness or affect your vision. If this occurs, do not drive, ride a bicycle, or use tools or machinery.

3. How to Take Spedra

Follow exactly the administration instructions for this medication as indicated by your doctor.

In case of doubt, consult your doctor or pharmacist.

The recommended dose is one 100 mg tablet as needed. Do not take Spedra more than once a day. Your doctor may prescribe a 200 mg tablet if they consider the 100 mg dose too weak for you, or a 50 mg tablet if they consider the 100 mg dose too strong. Additionally, the dose may need to be adjusted if Spedra is used with certain medications. If you are taking a medication, such as erythromycin, amprenavir, aprepitant, diltiazem, fluconazole, fosamprenavir, or verapamil (“moderate CYP3A4 inhibitors”), the maximum recommended dose of Spedra is one 100 mg tablet, with an interval of at least 2 days between doses.

Take Spedra approximately 15 to 30 minutes before sexual activity. Remember that Spedra will only help you achieve an erection if you receive sexual stimulation.

Spedra can be taken with or without food. If taken with food, it may take longer to act.

If you take too much Spedra

If you take too much Spedra, inform your doctor immediately. You may experience more adverse reactions than usual, and they may be more severe.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, it may cause side effects, although not everyone will experience them.

Severe side effects

Stop taking Spedra and consult a doctor immediately if you notice any of the following severe side effects, as you may require urgent medical treatment:

  • a prolonged erection (“priapism”). If the erection lasts more than 4 hours, it should be treated immediately as it may cause permanent damage to the penis (e.g. inability to achieve erections).
  • blurred vision.
  • sudden decrease or loss of vision in one or both eyes.
  • sudden decrease or loss of hearing (sometimes accompanied by dizziness or ringing in the ears).

Stop taking Spedra and consult a doctor immediately if you notice any of the above severe side effects.

Other side effects include:

Frequent (may affect up to 1 in 10 people)

  • headache
  • flushing (skin redness)
  • nasal congestion

Less common (may affect up to 1 in 100 people):

  • sensation of dizziness
  • sensation of intense sleepiness or fatigue
  • sinus congestion
  • lower back pain
  • angina
  • sensation of shortness of breath during exercise
  • changes in heart rhythm observed on an ECG
  • increased heart rate
  • sensation of heart palpitations
  • indigestion, nausea
  • blurred vision
  • elevation of liver enzyme levels

Rare (may affect up to 1 in 1,000 people)

  • flu
  • influenza-like illness
  • nasal congestion or discharge
  • allergic rhinitis (hay fever)
  • congestion in the nose, nasal sinuses, or upper respiratory tract
  • gout
  • insomnia (difficulty sleeping)
  • premature ejaculation
  • strange sensation
  • sensation of nervousness
  • chest pain
  • severe chest pain
  • tachycardia
  • hypertension
  • dry mouth
  • stomach pain or acid reflux
  • lower abdominal pain or discomfort
  • diarrhea
  • eruption
  • lower back or side pain
  • muscle pain
  • muscle spasms
  • frequent urination (frequent need to urinate)
  • penile disorders
  • spontaneous erections without sexual stimulation
  • itching in the genital area
  • persistent weakness or fatigue
  • swelling in the feet or ankles
  • hypertension
  • urine of pink or red color, blood in the urine
  • abnormal heart murmur
  • an abnormal result of a blood test for the prostate called “PSA”
  • an abnormal result of a blood test for bilirubin, a chemical compound produced from the normal breakdown of red blood cells
  • an abnormal result of a blood test for creatinine, a chemical compound excreted in the urine, which serves as a measure of kidney function
  • weight gain
  • fever
  • nasal bleeding

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system included in theAppendix V.By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of Spedra

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the blister pack and on the box after “CAD”: The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medicines should not be disposed of through the drains or in the trash. Ask your pharmacist how to dispose of the packaging and the medication that you no longer need. In this way, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of Spedra

  • The active ingredient is avanafil. Each tablet contains 100 mg of avanafil. The other components are mannitol, fumaric acid, hydroxypropylcellulose,
  • low-substituted hydroxypropylcellulose, calcium carbonate, magnesium stearate, and yellow iron oxide (E172).

Appearance of Spedra and contents of the package

Spedra is an oval-shaped yellowish tablet with “100” engraved on one side. The tablets are presented in pre-cut single-dose blisters containing 2x1, 4x1, 8x1, or 12x1 tablets.

Only some package sizes may be marketed in your country.

Marketing Authorization Holder:

MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A., 1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

Manufacturer:

Menarini - Von Heyden GmbH

Leipziger Straße 7-13

01097 Dresden, Germany.

or

Sanofi Winthrop Industrie

1, rue de la Vierge

Ambares et Lagrave

33565 Carbon-Blanc-Cedex

France

You can request more information about this medicine by contacting the local representative of themarketing authorization holder.

België/Belgique/BelgienMenarini Benelux NV/SA Tél/Tel: + 32 (0)2 721 4545

Lietuva

UAB “BERLIN-CHEMIE MENARINI

BALTIC”

Tel: +370 52 691 947

Luxembourg/LuxemburgMenarini Benelux NV/SA Tél/Tel: + 32 (0)2 721 4545

Ceská republika

Berlin-Chemie/A.Menarini Ceska republika

s.r.o.

Tel: +420 267 199 333

Magyarország

Berlin-Chemie/A. Menarini Kft.

Tel.: +36 23501301

DanmarkPharmaprim AB Tlf: +46 8355933

Malta

Menarini International Operations Luxembourg

S.A.

Tel: +352264976

Deutschland

Berlin-Chemie AG Tel: +49 (0) 30 67070

Nederland

Menarini Benelux NV/SA Tel: +32 (0)2 721 4545

Eesti

OÜ Berlin-Chemie Menarini Eesti Tel: +372 667 5001

NorgePharmaprim AB Tlf: +46 8355933

Ελλ?δα

MENARINI HELLAS AE Τηλ: +30 210 8316111-13

Österreich

A. Menarini Pharma GmbH Tel: +43 1 879 95 85-0

España

Laboratorios Menarini S.A. Tel: +34-93 462 88 00

Polska

Berlin-Chemie/Menarini Polska Sp. z o.o. Tel.: +48 22 566 21 00

France

MENARINI France

Tél: +33 (0)1 45 60 77 20

Portugal

A. Menarini Portugal – Farmacêutica, S.A.

Tel: +351 210 935 500

Hrvatska

Berlin-Chemie Menarini Hrvatska d.o.o. Tel: + 385 1 4821 361

România

Berlin-Chemie A. Menarini S.R.L.

Tel: +40 21 232 34 32

Ireland

A. Menarini Pharmaceuticals Ireland Ltd

Tel: +353 1 284 6744

Slovenija

Berlin-Chemie / A. Menarini Distribution

Ljubljana d.o.o. Tel: +386 01 300 2160

ÍslandPharmaprim AB Sími: +468355933

Slovenská republika

Berlin-Chemie / A. Menarini Distribution

Slovakia s.r.o Tel: +421 2 544 30 730

Italia

A. Menarini Industrie Farmaceutiche Riunite

s.r.l.

Tel: +39-055 56801

Suomi/Finland

Berlin-Chemie/A.Menarini Suomi OY Puh/Tel: +358 403 000 760

Κ?προς

MENARINI HELLAS AE Τηλ: +30 210 8316111-13

SverigePharmaprim AB Tel: +46 8355933

Latvija

SIA Berlin-Chemie/Menarini Baltic Tel: +371 67103210

United Kingdom (Northern Ireland)

A. Menarini Farmaceutica Internazionale S.R.L. Tel: +44 (0)1628 856400

Last update of this leaflet

The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.


Country of registration
Active substance
Prescription required
Yes
Composition
Manitol (e-421) (32 mg mg)
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.

Talk to a doctor online

Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.

5.01 review
Doctor

Anna Moret

Dermatology18 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

Book a video appointment
5.01 review
Doctor

Alina Tsurkan

Family Medicine12 years of experience

Dr. Alina Tsurkan is a licensed family medicine doctor based in Portugal. She provides personalised primary care for both adults and children, helping patients manage a wide range of everyday health concerns with professionalism and attention to detail.

Dr. Tsurkan diagnoses and treats common conditions such as: • Respiratory infections (cold, flu, bronchitis, pneumonia) • Eye conditions: conjunctivitis (infectious and allergic) • ENT problems (sinusitis, ear infections, tonsillitis) • Digestive issues including gastritis, acid reflux, and IBS • Urinary tract infections and other frequent infections • Chronic conditions such as high blood pressure, diabetes, and thyroid disorders • Headaches and migraines

In addition to symptom-based care, Dr. Tsurkan focuses on prevention and early detection. She offers regular health check-ups, follow-up care, and medical prescriptions tailored to each patient’s needs.

With a comprehensive and caring approach, Dr. Tsurkan supports patients at every stage of life — from acute illnesses to long-term health management.

Book a video appointment
5.09 reviews
Doctor

Andrei Popov

General Medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

Book a video appointment
5.01 review
Doctor

Yevgen Yakovenko

General Surgery11 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain, with a diverse clinical background in general and pediatric surgery, internal medicine, and pain management. With a strong focus on both practice and research, he provides comprehensive medical consultations for adults and children, covering both surgical and therapeutic needs.

Dr. Yakovenko offers expert care in the following areas: • Diagnosis and treatment of acute and chronic pain • Pre- and postoperative care, including risk assessment and follow-up • Surgical conditions such as hernias, gallbladder disease, and appendicitis • Pediatric surgery consultations, including congenital conditions and minor procedures • Trauma care: fractures, soft tissue injuries, and wound management • Oncological surgery consultation and post-treatment care • Cardiovascular and respiratory conditions (internal medicine) • Orthopedic concerns and post-trauma rehabilitation • Radiological interpretation for surgical planning

In addition to his clinical work, Dr. Yakovenko actively participates in medical research and international collaboration. He is a member of the German Surgeons Association (BDC), affiliated with the General Practitioners Association of Las Palmas, and works with the German Consulate in the Canary Islands. He regularly attends international medical conferences and has authored scientific publications.

With over a decade of multidisciplinary experience, Dr. Yakovenko delivers precise, evidence-based care tailored to each patient’s needs.

Book a video appointment
See all doctors

Stay informed and save on care

Get health tips, platform updates, and exclusive promos for subscribers.

Follow us on social media